Oxaprozin Capsule
NDC Package 70512-787-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Oxaprozin capsules is oxaprozin is used to treat arthritis. This formulation utilizes a capsule delivery system. Marketed by Sola Pharmaceuticals, Llc, this product is identified by NDC 70512-787 and is authorized under FDA application NDA217927.

Identification & Billing

NDC Package Code
70512-787-60
Package Description
60 CAPSULE in 1 BOTTLE
Product Code
70512-787
11-Digit Billing Format
70512078760
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA
RxNorm Crosswalk
RxCUI: 2668162 - oxaprozin 300 MG Oral Capsule

Clinical Specifications

Proprietary Name
Oxaprozin
Non-Proprietary Name
Oxaprozin
Substance Name
Oxaprozin
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
OXAPROZIN 300 mg/1
Pharmacologic Class
Usage Information
Oxaprozin is used to treat arthritis. It reduces pain, swelling, and stiffness of the joints. Oxaprozin is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

Regulatory & Marketing

Labeler Name
Sola Pharmaceuticals, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA217927
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-03-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70512-787-60 identifies a specific commercial package of 60 capsule in 1 bottle of Oxaprozin, a human prescription drug labeled by Sola Pharmaceuticals, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This capsule is formulated for oral use and contains oxaprozin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sola Pharmaceuticals, Llc on December 03, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Oxaprozin is used to treat arthritis. It reduces pain, swelling, and stiffness of the joints. Oxaprozin is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

How is this Sola Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70512078760. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70512-787-60
11-Digit CMS (5-4-2)
70512-0787-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.